Insider · CIK 0001891462
Carl Aure
cfoofficer
Files at LFVN (Lifevantage Corp). First filing Jul 3, 2025, latest Jul 3, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $37k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LFVN: Lifevantage Corp
LFVNOct 9, 2026 · close 6.00
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 13Weak | LFVNsell Lifevantage Corp | $37k 2,746 shares | -2% | +44% from low-47% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | LFVN Lifevantage Corp | AGrant or award Common Stock | +35,749 | $0.00 | $0 | 191,784 | 3 d ago |
| Oct 7, 2026 | LFVN Lifevantage Corp | AGrant or award Performance Restricted Stock Unitsderivative | +53,623 | $0.00 | $0 | 53,623 | 3 d ago |
| Oct 1, 2026 | LFVN Lifevantage Corp | FTax withholding Common Stock | -460 | $6.24 | $2,870 | 156,035 | 7 d ago |
| Sep 10, 2026 | LFVN Lifevantage Corp | FTax withholding Common Stock | -1,869 | $6.37 | $12k | 156,495 | 28 d ago |
| Oct 1, 2025 | LFVN Lifevantage Corp | FTax withholding Common Stock | -1,361 | $9.56 | $13k | 159,969 | Oct 3, 2025 |
| Aug 31, 2025 | LFVN Lifevantage Corp | MOption exercise Common Stock | +14,792 | $0.00 | $0 | 159,054 | Sep 3, 2025 |
| Aug 31, 2025 | LFVN Lifevantage Corp | MOption exercise Common Stock | +18,886 | $0.00 | $0 | 177,940 | Sep 3, 2025 |
| Aug 31, 2025 | LFVN Lifevantage Corp | FTax withholding Common Stock | -16,610 | $13.10 | $218k | 161,330 | Sep 3, 2025 |
| Aug 31, 2025 | LFVN Lifevantage Corp | MOption exercise Performance Restricted Stock Unitsderivative | -14,792 | $0.00 | $0 | 4,931 | Sep 3, 2025 |
| Aug 31, 2025 | LFVN Lifevantage Corp | MOption exercise Performance Restricted Stock Unitsderivative | -18,886 | $0.00 | $0 | 9,443 | Sep 3, 2025 |
| Aug 26, 2025 | LFVN Lifevantage Corp | AGrant or award Common Stock | +10,241 | $0.00 | $0 | 143,544 | Aug 28, 2025 |
| Aug 26, 2025 | LFVN Lifevantage Corp | AGrant or award Performance Restricted Stock Unitsderivative | +15,361 | $0.00 | $0 | 15,361 | Aug 28, 2025 |
| Jul 1, 2025 | LFVN Lifevantage Corp | MOption exercise Common Stock | +2,401 | $0.00 | $0 | 136,049 | Jul 3, 2025 |
| Jul 1, 2025 | LFVN Lifevantage Corp | SOpen-market sale Common Stock | -2,746 | $13.39 | $37k | 133,303 | Jul 3, 2025 |
| Jul 1, 2025 | LFVN Lifevantage Corp | MOption exercise Performance Restricted Stock Unitsderivative | -2,401 | $0.00 | $0 | 0 | Jul 3, 2025 |
| Apr 1, 2025 | LFVN Lifevantage Corp | MOption exercise Common Stock | +2,401 | $0.00 | $0 | 134,807 | Apr 3, 2025 |
| Apr 1, 2025 | LFVN Lifevantage Corp | FTax withholding Common Stock | -2,749 | $15.79 | $43k | 132,058 | Apr 3, 2025 |
| Apr 1, 2025 | LFVN Lifevantage Corp | MOption exercise Performance Restricted Stock Unitsderivative | -2,401 | $0.00 | $0 | 2,401 | Apr 3, 2025 |
| Jan 1, 2025 | LFVN Lifevantage Corp | MOption exercise Common Stock | +2,401 | $0.00 | $0 | 135,675 | Jan 3, 2025 |
| Jan 1, 2025 | LFVN Lifevantage Corp | FTax withholding Common Stock | -3,269 | $17.53 | $57k | 132,406 | Jan 3, 2025 |
| Jan 1, 2025 | LFVN Lifevantage Corp | MOption exercise Performance Restricted Stock Unitsderivative | -2,401 | $0.00 | $0 | 4,802 | Jan 3, 2025 |
| Nov 12, 2024 | LFVN Lifevantage Corp | FTax withholding Common Stock | -5,472 | $13.74 | $75k | 133,274 | Nov 13, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.